This is a single-center, prospective, and single-arm study. The purpose of this study is to evaluate the feasibility and safety of a new self-driving robotic-assisted bronchoscopic system for the diagnosis of peripheral pulmonary lesions.
Self-driving robotic-assisted bronchoscope (Shanghai MicroPort MedBot (Group) Corporation Limited, China) is a new robotic-assisted bronchoscopic system that can automatically advance through airway according to the preoperative planning path under the guidance of electromagnetic navigation. It can also be controlled manually by the operator. In this study, 30 patients will be prospectively enrolled to evaluate the feasibility and safety of this new self-driving robotic-assisted bronchoscopic system for the diagnosis of peripheral pulmonary lesions. The primary endpoint of this study is the complication rate. The secondary endpoints include navigation success rate, diagnostic yield, rate of rEBUS confirmation, total examination time, navigation time, and duration of finding lesions.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
30
All procedures will be performed under general anesthesia with endotracheal intubation and mechanical ventilation. The self-driving robotic-assisted bronchoscope will automatically advance through airway to the target lesion according to the preoperative planning path under the guidance of electromagnetic navigation. After that, the bronchoscopist will use radial endobronchial ultrasound (rEBUS) to confirm the lesion localization. The choice of biopsy tools (eg. forceps, needles, brush, etc.) will be left to the discretion of the bronchoscopist.
Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China
Complication rate
The complications refer to the total of device or procedure related adverse events during or within 1 month after the operation.
Time frame: 1 month
Navigation success rate
Navigation success is defined as confirmation of the target lesion under rEBUS or a bronchoscope tip-to-virtual lesion distance \<2 cm that allows lesion sampling. Cases in which a malignant or specific benign diagnosis is obtained are also considered as navigation success.
Time frame: 1 month
Diagnostic yield
Diagnostic yield of self-driving robotic-assisted bronchoscopy for peripheral pulmonary lesions.
Time frame: 1 month
Rate of rEBUS confirmation
rEBUS confirmation is defined as visualization of target lesion using rEBUS during the procedure.
Time frame: During the procedure
Total examination time
Total examination time is defined from the time that the bronchoscope is inserted beyond the glottis, until the bronchoscope has been removed from the glottis after examination.
Time frame: During the procedure
Navigation time
Navigation time is defined as the time from the start of the self-driving robotic-assisted bronchoscope advancing under the guidance of electromagnetic navigation to the insertion of the ultrasound probe.
Time frame: During the procedure
Duration of finding lesions
Duration of finding lesions is defined from the insertion of the ultrasound probe to the withdrawal of the ultrasound probe.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: During the procedure